Comparison between the Outcomes of Using Biodegradable-Polymer Drug-Eluting Stents and Those of Using Durable-Polymer Drug-Eluting Stents in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.
Abd-Allah Y FawzyMahmoud M KenawiAhmed Abd El AzizAyman N MoharamIbrahim M AttiaPublished in: Open access Macedonian journal of medical sciences (2019)
Biodegradable-polymer DES represents a comparable alternative to durable-polymer DES in the setting of acute coronary syndromes.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- antiplatelet therapy
- patients undergoing
- st segment elevation myocardial infarction
- drug delivery
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery bypass grafting
- coronary artery disease
- type diabetes
- atrial fibrillation
- metabolic syndrome
- adipose tissue
- weight loss
- adverse drug